Jenny Walsh

What About the Kids?

Since the late 1990s, new regulations have given us the opportunity to address the needs of the most vulnerable and demanding patients – children. Making medicines for pediatrics adds a whole new dimension to the challenges of formulation and drug delivery, but as our knowledge expands, exciting new developments are in the pipeline.